Leptin and Insulin Sensitivity: Endogenous Signals of Metabolic Homeostasis
The Journal of Clinical Endocrinology & Metabolism · 2024-04-19 · 109 (5) · e1402-e1403
DOI: 10.1210/clinem/dgad653 ↗At a glance
Editorial in The Journal of Clinical Endocrinology & Metabolism, published online on 2023-11-07. Written by Sam Dagogo-Jack. Institution: Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Major MEDLINE topics: Leptin, Insulin Resistance. Cited 20 times so far (Crossref); 8 references. Funded by: National Institute of Diabetes Digestive and Kidney Diseases.
Abstract (original language)
The frequent cross-sectional findings of insulin resistance, hyperinsulinemia, and hyperleptinemia in people with overweight or obesity present an interpretive conundrum. Does the hyperleptinemia merely reflect adiposity, and is it a cause or consequence of insulin resistance? Recently, Chiriacò and colleagues (1) analyzed data from the RISC (Relationship Between Insulin Sensitivity and Cardiovascular Disease) study and identified participants [n = 1,290 healthy adults; body mass index (BMI) 19-35 kg/m2] with relatively high leptin (RHL) or relatively low leptin (RLL) levels, based on sex-specific leptin vs fat mass regression (1). Metabolic assessments included glucose tolerance (75-g oral glucose tolerance test), insulin sensitivity, and β-cell function. The investigators found that individuals with RHL had hyperinsulinemia and lower insulin sensitivity than RLL individuals, regardless of adiposity (1). Plasma leptin levels are inversely correlated with insulin sensitivity (ie, directly correlated with insulin resistance); however, there is substantial heterogeneity. In 2010, Askari and colleagues showed that variations in plasma leptin levels among individuals with similar adiposity reflect ambient insulin sensitivity (2). Using data from hyperinsulinemic euglycemic clamps and regression analysis, healthy adults were stratified into 4 dyadic subgroups: (1) nonobese (BMI 27 kg/m2)/lower fasting leptin, and (4) overweight or obese/higher fasting leptin. Within each BMI bracket, individuals with lower leptin levels were found to have higher insulin sensitivity than those with higher leptin levels. In that study, insulin sensitivity explained ∼40% of the variance in fasting leptin levels (2). Another study showed that insulin-sensitive lean and obese phenotypes were associated with lower plasma leptin levels compared with insulin-resistant lean and obese phenotypes (3).
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
- General Clinical Research Center, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
ORCID profiles: Sam Dagogo-Jack
Funding
- National Institute of Diabetes Digestive and Kidney Diseases
Cite
APA
Dagogo-Jack, S. (2024). Leptin and Insulin Sensitivity: Endogenous Signals of Metabolic Homeostasis. The Journal of Clinical Endocrinology & Metabolism, 109(5), e1402-e1403. https://doi.org/10.1210/clinem/dgad653
Vancouver
Dagogo-Jack S. Leptin and Insulin Sensitivity: Endogenous Signals of Metabolic Homeostasis. The Journal of Clinical Endocrinology & Metabolism. 2024;109(5):e1402-e1403. doi:10.1210/clinem/dgad653
BibTeX
@article{DagogoJack2024,
author = {Dagogo-Jack, Sam},
title = {Leptin and Insulin Sensitivity: Endogenous Signals of Metabolic Homeostasis},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
volume = {109},
number = {5},
pages = {e1402--e1403},
doi = {10.1210/clinem/dgad653}
}
EUVIMED